You have 9 free searches left this month | to do more

Rifampin

Rifampin is a drug used to treat Healthy, Tuberculosis, Healthy Volunteers, and other conditions. Rifampin is being actively studied in 11 studies and prior, has been studied in 112.

Top SponsorsTop SitesTop Investigators
National Institute of Allergy and Infectious Diseases (NIAID)CelerionDr. Dick Menzies
PfizerBeth Israel Med CtrKevin Winthrop
Bristol-Myers SquibbCovance Clinical Research UnitCharlotte Schutz
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
A Study of Soticlestat and Rifampin in Healthy Adults - 2022
Completed
  • Healthy Volunteers
  • Belfast, United Kingdom
    Celerion
2022-03-04
Mar 4, 2022
A
Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult Participants - 2021
Completed
  • Healthy
  • Tempe, Arizona
    Clinical Trial Site
2021-12-08
Dec 8, 2021
C
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
Recruiting
  • Idiopathic Infantile Hypercalcaemia - Severe Form
  • +5 more
  • Rifampin
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
2022-02-28
Feb 28, 2022
A
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196 - 2014
Completed
  • Healthy Participants
  • Tempe, Arizona
    (unnamed)
2021-05-31
May 31, 2021
J
Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB
Recruiting
  • Tuberculosis, Pulmonary
  • Rifampin
  • +5 more
  • Stellenbosch, South Africa
    Task Applied Science and Stellenbosch University
2021-10-12
Oct 12, 2021
S
Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145 - 2013
Completed
  • Healthy
  • Lenexa, Kansas
    PRA International, Inc
2021-03-15
Mar 15, 2021
N
Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults - 2007
Completed
  • HIV Infections
  • Tuberculosis
  • Palo Alto, California
  • +2 more
2021-10-28
Oct 28, 2021
P
Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants
Withdrawn
  • Healthy Participants
  • Austin, Texas
    PPD Development, LP, 7551 Metro Center Drive, Suite 200
2022-02-10
Feb 10, 2022
J
A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants - 2021
Completed
  • Healthy
  • Tempe, Arizona
    Celerion
2021-02-25
Feb 25, 2021
O
The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors - 2021
Terminated
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +2 more
2021-07-26
Jul 26, 2021
L
Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants - 2020
Completed
  • Healthy Volunteers
  • Daytona Beach, Florida
    Covance Clinical Research Unit
2021-11-23
Nov 23, 2021
B
Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer - 2021
Completed
  • Solid Tumor
  • pamiparib (28 day cycles)
  • +4 more
  • Tbilisi, Georgia
  • +3 more
2021-08-12
Aug 12, 2021
R
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer - 2008
Completed
Has Results
  • Advanced Solid Tumors
  • Neoplasms
  • Cleveland, Ohio
    The Cleveland Clinic Foundation
2020-10-06
Oct 6, 2020
T
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects - 2017
Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Daytona Beach, Florida
    Covance Clinical Research Unit
2021-06-29
Jun 29, 2021
M
A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors - 2021
Completed
  • Advanced Solid Neoplasm
  • Atlanta, Georgia
  • +3 more
2021-03-08
Mar 8, 2021
P
Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600 - 2020
Completed
  • Healthy Volunteers
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
2020-09-14
Sep 14, 2020
M
A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants - 2019
Completed
Has Results
  • Healthy Volunteers
  • Lincoln, Nebraska
    Celerion
2020-11-13
Nov 13, 2020
M
A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants - 2019
Completed
Has Results
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
2020-08-11
Aug 11, 2020
P
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors - 2018
Completed
Has Results
  • Advanced Solid Tumors
  • Budapest, Hungary
  • +6 more
2021-06-01
Jun 1, 2021
C
Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects - 2019
Completed
  • Healthy Volunteers
  • Dallas, Texas
    Covance Clinical Research Unit Inc - Dallas
2020-08-19
Aug 19, 2020
U
Treatment of Latent TB Infection for Jailed Persons - 2009
Completed
Has Results
  • Tuberculosis
  • San Francisco, California
    University of California San Francisco
2020-07-13
Jul 13, 2020
P
A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 - 2020
Completed
  • Fungal Infection
  • Groningen, Netherlands
    PRA-EDS
2021-10-27
Oct 27, 2021
B
COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients - 2019
Completed
  • Medical Oncology
  • Copanlisib (BAY80-6946)
  • +2 more
  • Dallas, Texas
  • +4 more
2020-12-11
Dec 11, 2020
H
Fruquintinib CYP3A Inhibitor and Inducer Study - 2020
Completed
  • Drug Drug Interaction
  • Cypress, California
    WCCT
2021-06-16
Jun 16, 2021
P
Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842. - 2018
Completed
  • Healthy
  • Brussels, Belgium
    Pfizer Clinical Research Unit
2020-02-26
Feb 26, 2020